Variant report
Variant | nsv609793 |
---|---|
Chromosome Location | chr8:3807528-3811838 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs6984912 | chr8:3807528-3807529 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs77577234 | chr8:3807552-3807553 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs11786061 | chr8:3807553-3807554 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs148348053 | chr8:3807567-3807568 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs141538085 | chr8:3807568-3807569 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs147532771 | chr8:3807570-3807571 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs7004592 | chr8:3807593-3807594 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs188004563 | chr8:3807602-3807603 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs373412437 | chr8:3807632-3807633 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs538010167 | chr8:3807651-3807652 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs556408008 | chr8:3807653-3807654 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs375156450 | chr8:3807659-3807660 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs111291048 | chr8:3807660-3807661 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs2627515 | chr8:3807667-3807668 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs192133157 | chr8:3807687-3807688 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs140210328 | chr8:3807702-3807703 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs145336698 | chr8:3807719-3807720 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs147246367 | chr8:3807724-3807725 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs6984122 | chr8:3807730-3807731 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs10780168 | chr8:3807747-3807748 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs561945857 | chr8:3807753-3807754 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs529489665 | chr8:3807754-3807755 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs75478922 | chr8:3807756-3807757 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs111951547 | chr8:3807776-3807777 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs184682213 | chr8:3807779-3807780 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs139735088 | chr8:3807784-3807785 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs570017810 | chr8:3807795-3807796 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs188688458 | chr8:3807797-3807798 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs17401217 | chr8:3807818-3807819 | Weak transcription Enhancers Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs2740866 | chr8:3807826-3807827 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | mRNA abundance |
31 | rs535682168 | chr8:3807853-3807854 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
32 | rs149796341 | chr8:3807855-3807856 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
33 | rs11136684 | chr8:3807861-3807862 | Weak transcription Enhancers Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs539032746 | chr8:3807877-3807878 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
35 | rs2627514 | chr8:3807907-3807908 | Weak transcription Enhancers Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs11136685 | chr8:3807919-3807920 | Weak transcription Enhancers Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs2740865 | chr8:3807943-3807944 | Weak transcription Enhancers Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs555079993 | chr8:3807946-3807947 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
39 | rs79161602 | chr8:3807959-3807960 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
40 | rs552792847 | chr8:3807963-3807964 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
41 | rs538982565 | chr8:3807965-3807966 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
42 | rs541638049 | chr8:3807970-3807971 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
43 | rs367626261 | chr8:3807976-3807977 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
44 | rs533692844 | chr8:3807986-3807987 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
45 | rs545033435 | chr8:3807994-3807995 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
46 | rs192529193 | chr8:3807999-3808000 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
47 | rs530969244 | chr8:3808002-3808003 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
48 | rs756094 | chr8:3808005-3808006 | Weak transcription Enhancers Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs374484956 | chr8:3808008-3808009 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
50 | rs371679085 | chr8:3808015-3808016 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
abnormal development | 18461090 | CNVD |
Crohn''s disease | 19220326 | CNVD |
Psoriasis | 19220326 | CNVD |
Prostate cancer | 21965145 | CNVD |
Prostate cancer | 18515986 | CNVD |
Chronic obstructive pulmonary disease | 20378733 | CNVD |
Autism | 18414403 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 17603634 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical cancer | 17311676 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Schizophrenia | 20877625 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 17001317 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Epilepsy | 22083797 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Congenital diaphragmatic hernia | 21064195 | CNVD |
Breast cancer | 21364760 | CNVD |
Cancer | 20164920 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Prostate cancer | 17217626 | CNVD |
Developmental delay | 19128483 | CNVD |
Neuroticism | 17667963 | CNVD |
Leukoplakia | 24403051 | CNVD |
Intellectual disability | 22045946 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16608533 | CNVD |
Seminomas | 18059402 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Colorectal cancer | 22014273 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Cancer | 20164919 | CNVD |
Non-syndromic sensorineural hearing loss | 17289997 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Tetralogy of Fallot | 22912587 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:3794200-3810000 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
2 | chr8:3807200-3808200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
3 | chr8:3807800-3808200 | Active TSS | Pancreatic Islets | Pancreatic Islet |
4 | chr8:3807800-3808200 | Enhancers | Pancreas | Pancrea |
5 | chr8:3808200-3809600 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
6 | chr8:3809600-3810000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
7 | chr8:3809600-3810200 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
8 | chr8:3810000-3810400 | Enhancers | Cortex derived primary cultured neurospheres | brain |
9 | chr8:3810200-3811400 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
10 | chr8:3811200-3811600 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
11 | chr8:3811400-3811600 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |